Investing

More Bad News For Boston Scientific (BSX)

Boston Scientific is acting like its business is OK again after a string of bad news. The company is boasting that sales will rise 11% to 21% in 2007. For investors to believe this, they need to buy into the fact that most of the integration risks of the company’s $21 billion purchase of medical devices company Guidant is behing it.Boston Scientific is also asking Wall St. to believe that sales of its drug-coated stents ,which keep clogged arteries open, will improve. It is forecasting that stent sales could be as high as $2.7 billion next year. But, a number of studies show that stents may actually increase clotting and cause heart attacks. No wonder the company’s stock trades near its 52-week low with shares changing hands at about below $16, down from nearly $28 earlier in the period.Now, the news gets worse. A study published in the New England Journal of Medicine says that, in many cases, stent implants may not help patients at all. Treatment with drugs may well be just as effective in many patients, making stents unnecessay. The finding are particular harmful to the future of Boston Scientifc’s devices if their is a health concern associated with stent implants.Boston Scientifc obviously wants investors to think the worst is behind it and that 2007 will be a strong year. But, the evidence keeps contradicting that.Douglas A. McIntyre can be reached at [email protected]. He does not own securities in companies that he writes about.

Take Charge of Your Retirement: Find the Right Financial Advisor For You in Minutes (Sponsor)

Retirement planning doesn’t have to feel overwhelming. The key is finding professional guidance—and we’ve made it easier than ever for you to connect with the right financial advisor for your unique needs.

Here’s how it works: 

1️ Answer a Few Simple Questions

Tell us a bit about your goals and preferences—it only takes a few minutes!

2️ Get Your Top Advisor Matches

This tool matches you with qualified advisors who specialize in helping people like you achieve financial success.

3️ Choose Your Best Fit

Review their profiles, schedule an introductory meeting, and select the advisor who feels right for you.

Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.